What is the recommended acute management for an adult patient with a blood glucose concentration above 20 mmol/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Blood Glucose Above 20 mmol/L (360 mg/dL)

Immediately administer 0.1-0.15 units/kg of rapid-acting insulin subcutaneously (approximately 7-10 units for a 70 kg patient) and verify the absence of ketosis before proceeding with isolated hyperglycemia management. 1

Immediate Assessment (First 15 Minutes)

Critical first step: Rule out diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) before treating as isolated hyperglycemia. 1, 2

  • Check blood β-hydroxybutyrate or urine ketones immediately in all patients with Type 1 diabetes and insulin-treated Type 2 diabetes when glucose exceeds 16.5 mmol/L (300 mg/dL). 3, 1
  • Calculate effective osmolality using the formula: 2[measured Na (mEq/L)] + glucose (mg/dL)/18 to ensure <320 mOsm/kg. 3, 1
  • If ketones are elevated (β-hydroxybutyrate >1.5 mmol/L or urine ketones 2+), this is DKA requiring ICU transfer and IV insulin infusion. 3, 4
  • If osmolality ≥320 mOsm/kg with marked dehydration, this is HHS requiring ICU management. 3, 5

Treatment Protocol for Isolated Severe Hyperglycemia (No Ketosis/Normal Osmolality)

Insulin Administration

Give weight-based rapid-acting insulin subcutaneously as the primary intervention:

  • Administer 0.1-0.15 units/kg of rapid-acting insulin (lispro, aspart, or glulisine) subcutaneously. 1
  • For a 70 kg patient, this equals 7-10 units. 1
  • Do not use sliding scale insulin alone as it provides inadequate correction for this degree of hyperglycemia. 1
  • Avoid IV insulin infusion unless DKA/HHS develops or the patient cannot tolerate subcutaneous administration. 1

Hydration Strategy

Aggressive fluid replacement is essential:

  • If the patient can drink, administer 500-1000 mL of water or sugar-free fluids over 1-2 hours. 1
  • If oral intake is inadequate or patient is NPO, start IV 0.9% sodium chloride at 150-250 mL/hour. 1
  • Fluid replacement helps lower glucose through dilution and improved renal perfusion. 3, 6

Monitoring Parameters

Hourly glucose monitoring is mandatory initially:

  • Check capillary blood glucose every 1 hour until glucose reaches 11-14 mmol/L (200-250 mg/dL). 1, 4
  • Expect glucose decline of 50-75 mg/dL (2.8-4.2 mmol/L) per hour with appropriate insulin dosing. 3, 1
  • Once glucose stabilizes in the 11-14 mmol/L range, reduce monitoring to every 2 hours. 1
  • Recheck ketones if glucose remains >16.5 mmol/L after 2 hours to ensure DKA has not developed. 3, 1

Identify and Address Precipitating Factors

Investigate why hyperglycemia occurred:

  • Review recent insulin doses and adherence patterns to identify missed doses. 1
  • Screen for infection (urinary tract infection, pneumonia, skin/soft tissue infection) as the most common precipitant. 2, 6, 7
  • Check for concurrent illness or stress (myocardial infarction, stroke, pancreatitis). 8, 6
  • Review medications for recent corticosteroid initiation or dose increase. 1
  • If on insulin pump, check for malfunction (kinked tubing, site infection, pump failure). 1

Transition and Follow-Up Management

Once glucose reaches target range:

  • Resume usual insulin regimen if patient was previously on basal-bolus therapy, ensuring basal insulin was not missed. 1, 4
  • Consider temporary 10-20% increase in total daily insulin dose if no clear precipitant identified. 1
  • Schedule follow-up within 24-48 hours to reassess glycemic control and adjust insulin doses. 1

Critical Pitfalls to Avoid

Common errors that worsen outcomes:

  1. Never delay insulin administration while waiting for additional workup - glucose >20 mmol/L requires immediate treatment regardless of time of day. 1

  2. Never assume absence of ketosis without verification - at glucose levels >16.5 mmol/L, ketone measurement is mandatory in Type 1 diabetes and insulin-treated Type 2 diabetes. 3, 1

  3. Never use sliding scale insulin alone - weight-based dosing of rapid-acting insulin is far more effective than arbitrary sliding scales. 1

  4. Never withhold fluids - dehydration from osmotic diuresis is universal at this glucose level and must be corrected. 3, 6, 5

  5. Never stop monitoring prematurely - glucose can rebound after initial correction, requiring additional insulin doses. 1, 4

Special Considerations for DKA/HHS (If Ketosis or Hyperosmolarity Present)

If assessment reveals DKA or HHS, management changes dramatically:

  • Transfer to ICU immediately for continuous IV insulin infusion and intensive monitoring. 3, 2
  • Start IV regular insulin at 0.1 unit/kg/h (no bolus in pediatric patients; 0.15 unit/kg bolus in adults). 3
  • Aggressive IV fluid resuscitation with 0.9% NaCl at rates determined by degree of dehydration and hemodynamic status. 3, 5
  • Add dextrose 5% to IV fluids when glucose falls to 14 mmol/L (250 mg/dL) while continuing insulin to clear ketones. 3, 4
  • Monitor electrolytes, pH, and osmolality every 2-4 hours until stable. 3, 4
  • DKA resolution requires glucose <11 mmol/L (200 mg/dL), bicarbonate ≥18 mEq/L, and pH >7.3. 4
  • HHS resolution requires osmolality <300 mOsm/kg, corrected hypovolemia, and glucose <15 mmol/L. 5

References

Guideline

Management of Severe Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Resolving Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic ketoacidosis.

Nature reviews. Disease primers, 2020

Related Questions

What is the best course of action for a confused patient with hyperglycemia (elevated blood glucose levels)?
What is the protocol for managing Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)?
What is the most likely diagnosis for a 56‑year‑old female presenting with polyuria, polydipsia, dry mucous membranes, poor skin turgor, orthostatic hypotension, tachycardia, weight loss, blurred vision, fasting glucose 298 mg/dL, random glucose 342 mg/dL, hemoglobin A1c 10.2 %, positive urine glucose and ketones, and elevated serum osmolality?
What is the correct initial management for a dehydrated diabetic patient with hyperglycemia, vomiting, and a history of omitted insulin, presenting with severe illness and dehydration?
What is the treatment for a diabetic adult patient presenting with severe hyperglycemia (blood glucose level of 789 mg/dL)?
When is it appropriate to give oral nifedipine as an emergency treatment if it is the only drug in my first‑aid kit?
What is the next step after finding blood and protein on urinalysis?
How do I evaluate and treat an adult, especially an older patient on antihypertensive medications, who presents with hypotension?
When should I take a vitamin C (ascorbic acid) tablet relative to ferrous gluconate?
What is the recommended management for a patient presenting with an acute neurological deficit suggestive of stroke at a facility without computed tomography capability?
When is intramuscular vitamin K (phytonadione) indicated, and what are the recommended adult and newborn doses?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.